
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Community oncologists' perceptions and eligibility
Dr Lunning contrasts CAR T and transplant eligibility and recommends interim PET and MRD to identify candidates earlier.
Play episode from 13:28
Transcript


